Literature DB >> 23915766

Are self-administered or minimal therapist contact psychotherapies an effective treatment for irritable bowel syndrome (IBS): a systematic review.

Alyce Ahl1, Antonina Mikocka-Walus, Andrea Gordon, Jane M Andrews.   

Abstract

OBJECTIVE: Irritable bowel syndrome is a highly prevalent gastrointestinal condition that is known to be associated with maladaptive psychological coping and is extremely costly to the health-care system. Psychotherapy has been found to improve both physical and psychological symptoms in IBS. However, it is unknown whether 'no therapist' or 'minimal therapist' contact self-help psychotherapy programs are effective treatments for IBS. Thus, this paper aims to determine whether 'no therapist' or 'minimal therapist' contact self-help psychotherapy programs are effective treatments for IBS.
METHODS: A search of PubMed, SCOPUS, Cochrane Library, and Ebscohost research databases was conducted without language or date restriction in July 2012.
RESULTS: Nine relevant publications were included in the final review, all of which were randomized controlled trials (RCTs) and included an intervention that was primarily self-administered. It was found that 'no therapist' contact self-help programs are likely to have poor results due to lack of engagement in the program, whilst 'minimal therapist' contact programs appear to produce positive results in terms of symptom relief. Trends towards 'minimal therapist' contact self-help programs having a positive impact on quality of life (QOL) and psychological outcomes were evident.
CONCLUSION: 'Minimal therapist' contact psychotherapy programs have the potential to reduce healthcare seeking behaviour and potentially reduce healthcare costs. However, further studies need to be conducted to confirm this effect as there is poor standardisation in the measurements of the available studies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Functional gastrointestinal disorders; Irritable bowel syndrome; Psychotherapy; Self-administered; Self-help

Mesh:

Year:  2013        PMID: 23915766     DOI: 10.1016/j.jpsychores.2013.04.008

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  6 in total

Review 1.  Cognitive Behavioral Therapy for IBS: How Useful, How Often, and How Does It Work?

Authors:  Christopher D Radziwon; Jeffrey M Lackner
Journal:  Curr Gastroenterol Rep       Date:  2017-08-17

2.  Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme.

Authors:  Subhadra Evans; Lisa Olive; Madeleine Dober; Simon Knowles; Matthew Fuller-Tyszkiewicz; Eric O; Peter Gibson; Leanne Raven; Richard Gearry; Andrew McCombie; Leesa van Niekerk; Susan Chesterman; Daniel Romano; Antonina Mikocka-Walus
Journal:  BMJ Open       Date:  2022-06-10       Impact factor: 3.006

3.  Written expressive disclosure in adults with irritable bowel syndrome: A randomized controlled trial.

Authors:  Kelsey T Laird; Annette L Stanton
Journal:  Complement Ther Clin Pract       Date:  2021-03-31       Impact factor: 2.446

4.  Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial.

Authors:  Antonina Mikocka-Walus; Peter Bampton; David Hetzel; Patrick Hughes; Adrian Esterman; Jane M Andrews
Journal:  Int J Behav Med       Date:  2017-02

5.  Self-help guidebook improved quality of life for patients with irritable bowel syndrome.

Authors:  Antonius Schneider; Stefanie Rosenberger; Johanna Bobardt; Jessica Bungartz-Catak; Oxana Atmann; Bernhard Haller; Anne Kennedy; Paul Enck
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

6.  Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial.

Authors:  Christine Norton; Jonathan Syred; Sally Kerry; Micol Artom; Louise Sweeney; Ailsa Hart; Wladyslawa Czuber-Dochan; Stephanie J C Taylor; Borislava Mihaylova; Chris Roukas; Qasim Aziz; Laura Miller; Richard Pollok; Sonia Saxena; Imogen Stagg; Helen Terry; Zohra Zenasni; Lesley Dibley; Rona Moss-Morris
Journal:  Trials       Date:  2021-08-03       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.